Dan Fero

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

HealthTell, Inc. develops healthcare diagnosing tools for individuals to monitor their health status. It offers OneTest, a new technology for the early detection and monitoring of progressive diseases and the test is simple and inexpensive, and can be performed with only a single drop of blood. The company was founded in 2010 by Stephen Albert Johnston and Neal Woodbury and is headquartered in Chandler, AZ.

TOMA Biosciences, Inc. develops and provides DNA-based cancer testing technology. The company was founded by Hanlee Ji, Lincoln Nadauld, James M. Ford, and Calvin J. Kuo in 2011 and is headquartered in Foster City, CA.

Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA.

Audax Private Equity (Audax Private Equity) is a private equity subsidiary of 101 Huntington Holdings LLC founded in 1999 by Geoff S. Rehnert and Marc B. Wolpow. The firm is headquartered in Boston, Massachusetts and additional office in San Francisco, California.

The American Hospital Association owns and operates hospitals. Its services include patient care, conducting research and development projects on the structuring and delivery of health care services, and providing educational programs and opportunities. The company was founded in September 1899 and is headquartered in Chicago, IL.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

Primus Capital Partners, Inc. (Primus Capital) is a private equity firm founded in 1983 by Loyal Wilson. The firm is headquartered in Pepper Hike, Ohio.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

Waud Capital Partners LLC (Waud Capital Partners) is an Independent Private Equity firm. The firm is founded in 1993 by Reeve Byron Waud. It is headquartered in Chicago,US.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Kaiser Permanenente Ventures LLC (KP Ventures) is a venture capital subsidiary of Kaiser Permanente, Inc. founded in 1996 by Henry Kaiser and Dr. Sidney Garfield. The firm is headquartered in Oakland, California.

Glyphic Biotechnologies Inc is an American biotechnology company that develops a protein sequencing platform to provide researchers with new insights into biology and disease. Glyphic Biotechnologies was founded by Joshua Yang and Daniel Estandian, with Joshua Yang serving as the CEO since incorporation.

Alida Biosciences, Inc. is a company that focuses on understanding complex relationships in gene regulation and epigenetic markers. The company is based in San Diego, CA. The company's mission is to create innovative technology for reading the epitranscriptome, which encompasses all naturally occurring chemical modifications of RNA. The company works with pharmaceuticals, diagnostics, agricultural sciences, and other sectors to bring bespoke solutions to complex problems. The CEO of the company is Gudrun Stengel.

Trident Labs, Inc. engages in the operation of toxicology laboratories. It offers urine and oral fluid drug testing to help medical offices monitor adherence to prescription medication and abstinence from illicit drugs. The company is headquartered in Holland, MI.

Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021.

ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier.

Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.

Tower Arch Capital LLC (Tower Arch Capital) is a private equity firm founded in 2013 by Rhett Neuenschwander, David Parkin, Ryan Stratton and David Topham. The firm is headquartered in Draper, Utah.

BlueCat Networks, Inc. provides IP address management solutions. Its products include BlueCat address manager, DNS and DHCP server, threat protection, address manager for windows server, automation manager, connectors and device registration portal. The company was founded by Richard Hyatt and Michael Hyatt in 2001 and is headquartered in Toronto, Canada.

Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau.

Strata Decision Technology LLC develops and provides a financial analytics and performance platform. It offers healthcare providers in financial planning, decision support and continuous cost improvement. The company was founded in 1996 and is headquartered in Chicago, IL.